The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his ...
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources ...
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over ...
The mission of the Industrial Partnership team is to detect, promote, assist and protect the inventive activities from research (inventions, know-how and biological materials) conducted at the Institut Pasteur (and in some Institutes of its international network), and transfer there to industrial ...
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study ...
Scientists have discovered how some of these restriction factors inhibit HIV replication in lymphocytes. These proteins belong to the IFITM (interferon-induced transmembrane proteins) family; they are broad-spectrum antiviral proteins that act on a wide range of viruses including influenza, dengue, etc. Little was previously known about their effect on HIV-1.
Ebola: a new Institut Pasteur is soon to be created in Guinea
Press release |
Pr Christian Bréchot, President of the Institut Pasteur, will be in Guinea Friday 28th November 2014, alongside François Hollande, President of the French Republic. Two agreements will be signed, one with the government of Guinea and the other one with the French Agency for Development (AFD), allowing for the creation of a new Pasteur Institute in Conakry in late 2016. On Saturday 29th, Pr.
Chikungunya fever: Themis Bioscience’s vaccine candidate successful in phase 1
Press release |
The induction of neutralizing antibodies by a prophylactic Chikungunya vaccine candidate has now been confirmed by the final results of a phase 1 clinical trial, as well as its tolerability and safety. Detailed information of the trial has been presented at two international conferences.
The dynamics and infrastructure of research at the Institut Pasteur are geared towards providing research teams with the resources required for the realization of ambitious, innovative projects. Institut Pasteur's laboratories are composed of 130 research units and 14 technology platforms.
With 13 technological platforms in three clusters, as well as the Central Animal Facility, the Mouse Genetics Engineering Center, and the Center for the Production and Infection of Anopheles, the Institut Pasteur ensures that its teams have all of the resources they need to perform cutting-edge research.
National Reference Centers (CNRs) and World Health Organization Collaborating Centers (WHOCCs)
As microbiological observatories for communicable diseases, National Reference Centers (CNRs) and World Health Organization Collaborating Centers (WHOCCs) play an important part in the Institut Pasteur’s public health activities.